Genotype-phenotype correlation in Juvenile Paget disease: Role of molecular alterations of the TNFRSF11B gene

Endocrine

Volumn 42, Issue 2, 2012, Pages 266-271

  Brunetti, Giacomina ^a   Marzano, Flaviana ^a   Colucci, Silvia ^a   Ventura, Annamaria ^a   Cavallo, Luciano ^a   Grano, Maria ^a   Faienza, Maria Felicia ^a  

^a UNIVERSITY OF BARI   (Italy)

Author keywords

Genotype; Juvenile Paget disease (JPD); Osteoprotegerin; Phenotype

Indexed keywords

OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPROTEGERIN;

AMINO ACID SUBSTITUTION; AUTOSOMAL RECESSIVE DISORDER; BONE MALFORMATION; BONE PAIN; BONE TURNOVER; CHROMOSOME 8Q; GENE; GENE DELETION; GENE MUTATION; GENOTYPE PHENOTYPE CORRELATION; HUMAN; JUVENILE PAGET DISEASE; OSTEOCLASTOGENESIS; OSTEOPOROSIS; OSTEOSCLEROSIS; PAGET BONE DISEASE; PATHOLOGIC FRACTURE; PHENOTYPIC VARIATION; PRIORITY JOURNAL; REVIEW; TNFRSF11B GENE;

EID: 84867380685     PISSN: 1355008X     EISSN: 15590100     Source Type: Journal    
DOI: 10.1007/s12020-012-9705-0     Document Type: Review

References (56)

1. J.A. Kanis, Pathophysiology and Treatment of Paget's Disease of Bone (Martin Dunitz, London, 1998)
2. D.J. Hosking, Paget's disease of bone. BMJ 283, 686-688 (1981)
3. G.D. Roodman, J.J. Windle, Paget disease of bone. J. Clin. Invest. 115, 200-208 (2005)
4. A. Rebel, K. Malkani, M. Basle, C. Bregeon, A. Patezour, R. Filmon, Ultrastructural characteristics of osteoclasts in Paget's disease. Rev. Rhum. Mal. Osteoartic. 41, 767-771 (1974)
5. S.D. Neale, R. Smith, J.A. Wass, N.A. Athanasou, Osteoclast differentiation from circulating mononuclear precursors in Paget's disease is hypersensitive to 1,25-dihydroxyvitamin D1 and RANKL. Bone 27, 409-416 (2000)
6. A. Kukita, C. Chenu, L.M. McManus, G.R. Mundy, G.D. Roodman, Atypical multinucleated cells form in long-term marrow cultures from patients with Paget's disease. J. Clin. Invest. 85, 1280-1286 (1990)
7. D. Naot, U. Bava, B. Matthews, K.E. Callon, G.D. Gamble, M. Black, S. Song, R.P. Pitto, T. Cundy, J. Cornish, I.R. Reid, Differential gene expression in cultured osteoblasts and bone marrow stromal cells from patients with Paget's disease of bone. J. Bone Miner. Res. 22, 298-309 (2007)
8. A. Demulder, S. Takahashi, F.R. Singer, D.J. Hosking, G.D. Roodman, Abnormalities in osteoclast precursors and marrow accessory cells in Paget's disease. Endocrinology 133, 1978-1982 (1993)
9. C. Menaa, S.V. Reddy, N. Kurihara, H. Maeda, D. Anderson, T. Cundy, J. Cornish, F.R. Singer, J.M. Bruder, G.D. Roodman, Enhanced RANK ligand expression and responsivity of bone marrow cells in Paget's disease of bone. J. Clin. Invest. 105, 1833-1838 (2000)
10. G. Martini, L. Gennari, D. Merlotti, S. Salvadori, M.B. Franci, S. Campagna, A. Avanzati, V. De Paola, F. Valleggi, R. Nuti, Serum OPG and RANKL levels before and after intravenous bisphosphonate treatment in Paget's disease of bone. Bone 40, 457-463 (2007)
11. S. Seitz, M. Priemel, J. Zustin, F.T. Beil, J. Semler, H. Minne, T. Schinke, M. Amling, Paget's disease of bone: histologic analysis of 754 patients. J. Bone Miner. Res. 24, 62-69 (2009)
12. P.L. Selby, M.W. Davie, S.H. Ralston, M.D. Stone, Bone and Tooth Society of Great Britain, National Association for the Relief of Paget's Disease, Guidelines on the management of Paget's disease of bone. Bone 31, 366-373 (2002)
13. A.T. Deyrup, A.G. Montag, C.Y. Inwards, Z. Xu, R.G. Swee, U.K. Krishnan, Sarcomas arising in Paget disease of bone: a clinicopathologic analysis of 70 cases. Arch. Pathol. Lab. Med. 131, 942-946 (2007)
14. M.F. Hansen, M.J. Nellissery, P. Bhatia, Common mechanisms of osteosarcoma and Paget's disease. J. Bone Miner. Res. 14, 39-44 (1999)
15. H.J. Mankin, F.J. Hornicek, Paget's sarcoma: a historical and outcome review. Clin. Orthop. Relat. Res. 438, 97-102 (2005)
16. D.J. Barker, M.J. Gardner, Distribution of Paget's disease in England, Wales and Scotland and a possible relationship with vitamin D deficiency in childhood. Br. J. Prev. Soc. Med. 28, 226-232 (1974)
17. E.S. Siris, Epidemiological aspects of Paget's disease: family history and relationship to other medical conditions. Semin. Arthritis Rheum. 23, 222-225 (1994)
18. G. Lopez-Abente, A. Morales-Piga, A. Elena-Ibanez, J.S. Rey-Rey, J. Corres-Gonzalez, Cattle, pets, and Paget's disease of bone. Epidemiology 8, 247-251 (1997)
19. E.S. Siris, Seeking the elusive aetiology of Paget's disease: a progress report. J. Bone Miner. Res. 11, 1599-1601 (1996)
20. J.H. Lever, Paget's disease of bone in Lancashire and arsenic pesticide in cotton mill wastewater: a speculative hypothesis. Bone 31, 434-436 (2002)
21. M.T. Gordon, D.C. Anderson, P.T. Sharpe, Canine distemper virus localised in bone cells of patients with Paget's disease. Bone 12, 195-201 (1991)
22. M.H. Helfrich, R.P. Hobson, P.S. Grabowski, A. Zurbriggen, S.L. Cosby, G.R. Dickson, W.D. Fraser, C.G. Ooi, P.L. Selby, A.J. Crisp, R.G. Wallace, S. Kahn, S.H. Ralston, A negative search for a paramyxoviral etiology of Paget's disease of bone: molecular, immunological, and ultrastructural studies in UK patients. J. Bone Miner. Res. 15, 2315-2329 (2000)
23. C.G. Ooi, C.A. Walsh, J.A. Gallagher, W.D. Fraser, Absence of measles virus and canine distemper virus transcripts in long-term bone marrow cultures from patients with Paget's disease of bone. Bone 27, 417-421 (2000)
24. S.V. Reddy, F.R. Singer, G.D. Roodman, Bone marrow mononuclear cells from patients with Paget's disease contain measles virus nucleocapsid messenger ribonucleic acid that has mutations in a specific region of the sequence. J. Clin. Endocrinol. Metab. 80, 2108-2111 (1995)
25. A. Falchetti, F. Marini, L. Masi, A. Amedei, M.L. Brandi, Genetic aspects of the Paget's disease of bone: concerns on the introduction of DNA-based tests in the clinical practice. Advantages and disadvantages of its application. Eur. J. Clin. Invest. 40, 655-667 (2010)
26. L. Gennari, F. Gianfrancesco, M. Di Stefano, D. Rendina, D. Merlotti, T. Esposito, S. Gallone, P. Fusco, I. Rainero, P. Fenoglio, M. Mancini, G. Martini, S. Bergui, G. De Filippo, G. Isaia, P. Strazzullo, R. Nuti, G. Mossetti, SQSTM1 gene analysis and gene-environment interaction in Paget's disease of bone. J. Bone Miner. Res. 25, 1375-1384 (2010)
27. M.H. Helfrich, L.J. Hocking, Genetics and aetiology of Pagetic disorders of bone. Arch. Biochem. Biophys. 473, 172-182 (2008)
28. G.J. Lucas, A. Daroszewska, S.H. Ralston, Contribution of genetic factors to the pathogenesis of Paget's disease of bone and related disorders. J. Bone Miner. Res. 21, 31-37 (2006)
29. P.H. Osterberg, R.G. Wallace, D.A. Adams, R.S. Crone, G.R. Dickson, J.A. Kanis, R.A. Mollan, N.C. Nevin, J. Sloan, P.G. Toner, Familial expansile osteolysis. A new dysplasia. J. Bone Joint Surg. Br. 70, 255-260 (1988)
30. M.P. Whyte, B.G. Mills, W.R. Reinus, M.N. Podgornik, G.D. Roodman, F.H. Gannon, M.C. Eddy, W.H. McAlister, Expansile skeletal hyperphosphatasia: a new familial metabolic bone disease. J. Bone Miner. Res. 15, 2330-2344 (2000)
31. K. Nakatsuka, Y. Nishizawa, S.H. Ralston, Phenotypic characterization of early onset Paget's disease of bone caused by a 27-bp duplication in the TNFRSF11A gene. J. Bone Miner. Res. 18, 1381-1385 (2003)
32. M.P. Whyte, S.E. Obrecht, P.M. Finnegan, J.L. Jones, M.N. Podgornik, W.H. McAlister, S. Mumm, Osteoprotegerin deficiency and juvenile Paget's disease. N. Engl. J. Med. 347, 175-184 (2002)
33. M.J. Kovach, B. Waggoner, S.M. Leal, D. Gelber, R. Khardori, M.A. Levenstien, C.A. Shanks, G. Gregg, M.T. Al Lozi, T. Miller, W. Rakowicz, G. Lopate, J. Florence, G. Glosser, Z. Simmons, J.C. Morris, M.P. Whyte, A. Pestronk, V.E. Kimonis, Clinical delineation and localization to chromosome 9p13.3-p12 of a unique dominant disorder in four families: hereditary inclusion body myopathy, Paget disease of bone, and frontotemporal dementia. Mol. Genet. Metab. 74, 458-475 (2001)
34. O. Blanco, M. Stivel, C. Mautalen, F. Schajowicz, Familial idiopathic hyperphosphatasia: a study of two young siblings treated with porcine calcitonin. J. Bone Joint Surg. Br. 59, 421-427 (1977)
35. D.S. Golob, W.H. McAlister, B.G. Mills, K.N. Fedde, W.R. Reinus, S.L. Teitelbaum, S. Beeki, M.P. Whyte, Juvenile Paget disease: life-long features of a mildly affected young woman. J. Bone Miner. Res. 11, 132-142 (1996)
36. R.C. Thompson Jr, G.E. Gaul, S.J. Horowitz, R.K. Schenk, Hereditary hyperphosphatasia. Studies of three siblings. Am. J. Med. 47, 209-219 (1969)
37. J. Caffey, Familial hyperphosphatasemia with ateliosis and hypermetabolism of growing membranous bone; review of the clinical, radiographic and chemical features. Bull. Hosp. Jt. Dis. 33, 81-110 (1972)
38. S. Jett, H.M. Frost, Tetracycline-based measurements of the bone dynamics in the rib of a girl with hyperphosphatasia. Henry Ford Hosp. Med. J. 16, 325-338 (1968)
39. S.M. Mitsudo, Chronic idiopathic hyperphosphatasia associated with pseudoxanthonia elasticurn. J. Bone Joint Surg. Am. 53, 303-314 (1971)
40. M.P. Desai, N.C. Joshi, K.N. Shah, Chronic idiopathic hyperphosphatasia in an Indian child. Am. J. Dis. Child. 126, 626-628 (1973)
41. M.T. Duillo, A. Pelizza, G. Caramia, Chronic idiopathic hyperphosphatasia: a case with malabsorption syndrome. Panminerva Med. 19, 53-64 (1977)
42. E.J. Eyring, E. Eisenberg, Congenital hyperphosphatasia. A clinical, pathological, and biochemical study of two cases. J. Bone Joint Surg. Am. 50, 1099-1117 (1968)
43. G.N. Stemmermann, An histologic and histochemical study of familial osteoectasia. (Chronic idiopathic hyperphosphatasia). Am. J. Pathol. 48, 641-651 (1966)
44. V. Dunn, V.R. Condon, M.L. Rallison, Familial hyperphosphatasemia: diagnosis in early infancy and response to human thyrocalcitonin therapy. AJR Am. J. Roentgenol. 132, 541-545 (1979)
45. T.A. Einhorn, V.J. Vigorita, J.B. Teitcher, Hyperphosphatasemia in an adult. Clinical, roentgenographic, and histomorphometric findings and comparison to classical Paget's disease. Clin. Orthop. Relat. Res. 204, 253-260 (1986)
46. M. Eroglu, N.N. Taneli, Congenital hyperphosphatasia (juvenile Paget's disease). Eleven years follow-up of three sisters. Ann. Radiol. 20, 145-150 (1977)
47. T.C. Iancu, G. Almagor, E. Friedman, R. Hardoff, D. Front, Chronic familial hyperphosphatasemia. Radiology 129, 669-676 (1978)
48. B. Chong, M. Hedge, M. Fawkner, S. Simonet, H. Cassinelli, M. Coker, J. Kanis, J. Seidel, C. Tau, B. Tuysuz, B. Yuksel, D. Love, T. Cundy, Idiopathic hypershosphatasia and TNFRSF11B mutations: relationships between phenotype and genotype. J. Bone Miner. Res. 18, 2095-2104 (2003)
49. T. Cundy, M. Hegde, D. Naot, B. Chong, A. King, R. Wallace, J. Mulley, D.R. Love, J. Seidel, M. Fawkner, T. Banovic, K.E. Callon, A.B. Grey, I.R. Reid, C.A. Middleton-Hardie, J. Cornish, A mutation in the gene TNFRSF11B encoding osteoprotegerin causes an idiopathic hyperphosphatasia phenotype. Hum. Mol. Genet. 11, 2119-2127 (2002)
50. W.J. Boyle, W.S. Simonet, D.L. Lacey, Osteoclast differentiation and activation. Nature 423, 337-342 (2003)
51. N. Bucay, I. Sarosi, C.R. Dunstan, S. Morony, J. Tarpley, C. Capparelli, S. Scully, H.L. Tan, W. Xu, D.L. Lacey, W.J. Boyle, W.S. Simonet, Osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification. Genes Dev. 12, 1260-1268 (1998)
52. W.S. Simonet, D.L. Lacey, C.R. Dunstan, M. Kelley, M.S. Chang, R. Lüthy, H.Q. Nguyen, S. Wooden, L. Bennett, T. Boone, G. Shimamoto, M. DeRose, R. Elliott, A. Colombero, H.L. Tan, G. Trail, J. Sullivan, E. Davy, N. Bucay, L. Renshaw-Gegg, T.M. Hughes, D. Hill, W. Pattison, P. Campbell, S. Sander, G. Van, J. Tarpley, P. Derby, R. Lee, W.J. Boyle, Osteoprotegerin: a novel secreted protein involved in the regulation of bone density. Cell 89, 309-319 (1997)
53. M.P. Whyte, Paget's disease of bone and genetic disorders of RANKL/OPG/RANK/NF-kappaB signalling. Ann. NY. Acad. Sci. 1068, 143-164 (2006)
54. C. Middleton-Hardie, Q. Zhu, H. Cundy, J.M. Lin, K. Callon, P.C. Tong, J. Xu, A. Grey, J. Cornish, D. Naot, Deletion of aspartate 182 in OPG causes juvenile Paget's disease by impairing both protein secretion and binding to RANKL. J. Bone Miner. Res. 21, 438-445 (2006)
55. K. Janssens, M.C. de Vernejoul, F. de Freitas, F. Vanhoenacker, W. Van Hul, An intermediate form of juvenile Paget's disease caused by a truncating TNFRSF11B mutation. Bone 36, 542-548 (2005)
56. T. Cundy, J. Davidson, M.D. Rutland, C. Stewart, A.M. DePaoli, Recombinant osteoprotegerin for juvenile Paget's disease. N. Engl. J. Med. 353, 918-923 (2005)